Solitary Bone Metastasis Appearing outside the Usual Range of FDG PET/CT in Stage III Lung Cancer: Is Total Body FDG PET/CT Imaging Mandatory?JC Fanggiday*, W Uyterlinde, MM van den Heuvel and RA Valdés Olmos
Department of Heart and Lung, University Medical Center Utrecht, Utrecht, The Netherlands
- *Corresponding Author:
- JC Fanggiday
Department of Heart and Lung
University Medical Center Utrecht
Utrecht, The Netherlands
E-mail: [email protected]
Received date: July 14, 2012; Accepted date: July 26, 2012; Published date: July 29, 2012
Citation: Fanggiday JC, Uyterlinde W, van den Heuvel MM, Valdés Olmos RA (2012) Solitary Bone Metastasis Appearing outside the Usual Range of FDG PET/ CT in Stage III Lung Cancer: Is Total Body FDG PET/CT Imaging Mandatory? J Nucl Med Radiat Ther 3:135. doi: 10.4172/2155-9619.1000135
Copyright: © 2012 Fanggiday JC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Nowadays, 18-fluorodeoxyglucose positron emission tomography (18-FDG/PET) and computed tomography (CT) are frequently used in the diagnosis and staging of lung cancer. Usually, FDG-PET/CT images are taken from cranium or skull base to the groin, which covers most of the potential locations of metastasis. We describe three cases of stage IIIB NSCLC with unexpected stage-changing solitary bone metastasis outside the usual range of FDG PET/CT. We discuss whether a total body PET/CT should be performed on a regular basis. In addition, we propose a practical solution that is applicable in each clinic, to assess the whole body “on demand”, without compromising the logistics in a busy PET/CT clinic.